AU2001225432A1 - Novel podophyllotoxin compositions - Google Patents

Novel podophyllotoxin compositions

Info

Publication number
AU2001225432A1
AU2001225432A1 AU2001225432A AU2543201A AU2001225432A1 AU 2001225432 A1 AU2001225432 A1 AU 2001225432A1 AU 2001225432 A AU2001225432 A AU 2001225432A AU 2543201 A AU2543201 A AU 2543201A AU 2001225432 A1 AU2001225432 A1 AU 2001225432A1
Authority
AU
Australia
Prior art keywords
compositions
podophyllotoxin
discloses
present
novel podophyllotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001225432A
Inventor
Valery Alakhov
Evgueni Klinski
Shengmin Li
Olivier Lutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supratek Pharma Inc
Original Assignee
Supratek Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supratek Pharma Inc filed Critical Supratek Pharma Inc
Publication of AU2001225432A1 publication Critical patent/AU2001225432A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention discloses compositions comprising podophyllotoxins, analogs thereof, or derivatives thereof, and a surfactant. The invention also discloses a podophyllotoxin composition further comprising a targeting moiety. The present invention also discloses a method of delivering a podophyllotoxin, an analog thereof or a derivative thereof, to a cell by administering the described podophylootoxin compositions. Further, the present invention discloses a method of making the podophyllotoxin compositions.
AU2001225432A 2000-01-20 2001-01-11 Novel podophyllotoxin compositions Abandoned AU2001225432A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48829800A 2000-01-20 2000-01-20
US09488298 2000-01-20
PCT/IB2001/000087 WO2001052826A2 (en) 2000-01-20 2001-01-11 Novel podophyllotoxin compositions

Publications (1)

Publication Number Publication Date
AU2001225432A1 true AU2001225432A1 (en) 2001-07-31

Family

ID=23939161

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001225432A Abandoned AU2001225432A1 (en) 2000-01-20 2001-01-11 Novel podophyllotoxin compositions

Country Status (8)

Country Link
US (1) US20060148728A1 (en)
EP (1) EP1251858B1 (en)
JP (1) JP2003520227A (en)
AT (1) ATE297209T1 (en)
AU (1) AU2001225432A1 (en)
CA (1) CA2397871A1 (en)
DE (1) DE60111352T2 (en)
WO (1) WO2001052826A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102168D0 (en) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
JP2005514438A (en) 2001-12-21 2005-05-19 ソーン， デイビッド エス． Use of oligomers and polymers for solubilization, stabilization and delivery of drugs
US7846422B2 (en) * 2003-08-04 2010-12-07 Kao Corporation Method for prevention or treatment of periodontal diseases and composition for an oral cavity
US20080299205A1 (en) * 2004-07-19 2008-12-04 Mayer Lawrence D Particulate Constructs For Release of Active Agents
EP2240176A2 (en) * 2008-01-03 2010-10-20 Do-Coop Technologies Ltd Compositions and methods for enhancing the activity of podophyllotoxin
CN103080125A (en) 2010-07-02 2013-05-01 安吉奥开米公司 Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN102423302A (en) * 2011-11-21 2012-04-25 中国药科大学 Picropodophyllin-carrying nano micelle preparation and picropodophyllin-carrying nano micelle freezing and drying preparation and preparation method thereof
CN102526226A (en) * 2011-12-31 2012-07-04 沈阳药科大学 Application of traditional Chinese medicine prescription in aspect of relieving liver and kidney toxicity
CN103304574A (en) * 2013-03-29 2013-09-18 西南交通大学 Anticancer 4'-nor-anthricin and preparation method thereof
CN104415194A (en) * 2013-09-11 2015-03-18 罗兴富 Novel medicine for treating cervical tuberculous lymphadenitis and preparation method thereof
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
CN104435117A (en) * 2014-12-12 2015-03-25 王正琦 Traditional Chinese medicine composition for treating lymphangioma
CN104958547A (en) * 2015-06-26 2015-10-07 四川金堂海纳生物医药技术研究所 Orally-taken scrofula eliminating soup capable of treating scrofula and preparing method
RU2674029C1 (en) * 2017-08-24 2018-12-04 Илья Александрович Марков Rectal suppositories and method for preparation thereof (options)
WO2019051733A1 (en) * 2017-09-14 2019-03-21 顾崧 Method for preparing etoposide micelle
CN108552095B (en) * 2018-03-15 2020-08-21 浙江省淡水水产研究所 Treatment method of water for seedling safety
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
CN113750255B (en) * 2021-09-30 2023-10-31 大连民族大学 Environment-responsive hyaluronic acid-podophyllotoxin prodrug micelle and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
AU684950B2 (en) * 1994-05-06 1998-01-08 Alcon Laboratories, Inc. Use of vitamin E tocopheryl derivatives in ophthalmic compositions
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
KR0180334B1 (en) * 1995-09-21 1999-03-20 김윤 Drug messenger using el-2l-2 micelle and method for sealing drug to it
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
WO1998008490A1 (en) * 1996-09-01 1998-03-05 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes

Also Published As

Publication number Publication date
EP1251858A2 (en) 2002-10-30
CA2397871A1 (en) 2001-07-26
WO2001052826A2 (en) 2001-07-26
EP1251858B1 (en) 2005-06-08
US20060148728A1 (en) 2006-07-06
DE60111352T2 (en) 2006-05-04
DE60111352D1 (en) 2005-07-14
JP2003520227A (en) 2003-07-02
WO2001052826A3 (en) 2002-03-14
ATE297209T1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
AU2001225432A1 (en) Novel podophyllotoxin compositions
DE69831868D1 (en) Antithrombosemittel
MXPA02007942A (en) Pyrrolopyrimidinone derivatives, process of preparation and use.
AU2001289820A1 (en) Novel pharmaceutical composition for administering n-0923
HK1058934A1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
BG103795A (en) Pharmaceutical compositions with appetite suppressing activity
DK1157037T3 (en) G-CSF-conjugates
MXPA03002779A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same.
AUPR213700A0 (en) Antiviral agents
BG105564A (en) Galantamine-containing composition with controlled release
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
BRPI0113162B8 (en) non-imidazole aryloxyalkylamine compounds and pharmaceutical composition comprising said compounds
RS20100077A (en) Pharamceutically active uridine esters
MY127953A (en) Gabapentin-containing solid compositions and process for preparing the same
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
MXPA02009643A (en) Shortened synthesis of 3,3-diarylpropylamine derivatives.
CA2429639A1 (en) Stable azithromycin monohydrate
DE60114640D1 (en) Antithrombosemittel
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
YU72802A (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
MY139409A (en) Benzoxazine and quinoxaline and uses
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
WO2000056304A3 (en) Anti-inflammatory uses of manzamines
EP0414903A4 (en) New thioproline derivative
EP1321141A4 (en) Parathyroid hormone production inhibitors containing vitamin d3 derivatives